Arteriotomy Closure Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033

Arteriotomy Closure Devices Market Report Overview

The arteriotomy closure devices market size was $820.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Arteriotomy closure devices are used to achieve the hemostasis of an arterial puncture site after an angiography procedure, percutaneous coronary intervention, or a peripheral intervention. Such devices are used to decrease vascular complications and reduce the time required for hemostasis and ambulation compared to traditional methods.

Arteriotomy Closure Devices Market Outlook, 2023-2033 ($ Million)

Buy the Full Report for More Insights into the Arteriotomy Closure Devices Market Forecast

Download a Free Report Sample

The Arteriotomy Closure Devices market research report has been created to understand market behavior, which will help identify quantitative market trends in the cardiovascular devices therapeutic area. The model discusses in detail the impact of COVID-19 on the arteriotomy closure devices market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing your in-licensing and out-licensing strategies.

Arteriotomy Closure Devices Market Dynamics

The arteriotomy closure devices market will grow steadily over the forecast period due to the rising elderly population, increasing health awareness in emerging markets, and the development of advanced treatment methods. The percentage of Angina Pectoris (AP), myocardial infarction (MI), and Peripheral artery disease (PAD) patients requiring Arteriotomy Closure devices is expected to increase in the forecast period. Additionally, the rising prevalence of cardiovascular diseases, increasing incidences of vascular disorders, and a rise in the geriatric population will drive the adoption of arteriotomy closure devices in the market.

Arteriotomy Closure Devices Market Segments

The key segments in the arteriotomy closure devices market are active closure devices and passive closure devices. Active closure devices led the arteriotomy closure devices market in 2023. Active closure devices are used for the percutaneous closure of artery access sites in patients who have undergone diagnostic endovascular catheterization procedures. Hemostasis is carried out by these devices either by a collagen plug, suture, or clip.

Passive closure devices provide controlled compression of the percutaneous access arteries without completely occluding vessel flow. Hemostasis is achieved through sealant and an adjustable band. One unit refers to one passive closure device.

Arteriotomy Closure Devices Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment Insights into the Arteriotomy Closure Devices Market

Download a Free Report Sample

Arteriotomy Closure Devices Market Segmentation by Regions

The key regions in the arteriotomy closure devices market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, North America had the highest share of the arteriotomy closure devices market due to highly developed healthcare sectors and technological advancements in arteriotomy closure devices. Factors that might hinder market growth are lifestyle changes, patient awareness about the warning signs and symptoms of heart disease, and availability of alternative treatment options such as medication.

Arteriotomy Closure Devices Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Arteriotomy Closure Devices Market

Download a Free Report Sample

Arteriotomy Closure Devices Market - Competitive Landscape

A few of the leading companies in the arteriotomy closure devices market are:

• Terumo Corp
• Abbott Laboratories
• Cordis Corp
• Teleflex Inc
• Haemonetics Corp

Terumo Corp dominated the market in 2023. Terumo Medical Corp and Abbott Laboratories leads the market for arteriotomy closure devices by implementing strategies like innovation of new therapies and penetrating into the new and emerging markets. These are the dominant players in this field and have a broad portfolio within cardiac, pulmonary, vascular therapies and intensive care products.

Arteriotomy Closure Devices Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company Insights into the Arteriotomy Closure Devices Market

Download a Free Report Sample

Segments Covered in the Report

Arteriotomy Closure Devices Segments Outlook (Value, $ Million, 2015-2033)

• Active Closure Devices
• Passive Closure Devices

Arteriotomy Closure Devices Regional Outlook (Value, $ Million, 2015-2033)

• North America
• Europe
• Asia Pacific
• South Central America
• Middle East & Africa

Key Inclusions

Currently marketed Arteriotomy Closure Devices and evolving competitive landscape:

• Insightful review of the key industry trends.
• Annualized total Arteriotomy Closure Devices market revenue by segment and market outlooks from 2015-2033.
• Market-level data on units, average selling prices, and market values.

Global, Regional, and Country level market specific insights:

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Arteriotomy Closure Devices market.
• Competitive dynamics insights and trends provided for the Arteriotomy Closure Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Terumo Corp, Abbott Laboratories, Hellman and Friedman LLC, Teleflex Inc, Haemonetics Corp, Merit Medical Systems Inc, Marine Polymer Technologies Inc, Biolife LLC, Medtronic Plc, LeMaitre Vascular Inc, Advanced Vascular Dynamics, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This report provides:

• Insightful review of the key industry trends.
• Annualized total Arteriotomy Closure Devices market revenue by segment and market outlooks.
• Market-level data on units, average selling prices, and market values.
• Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Arteriotomy Closure Devices market.
• Competitive dynamics insights and trends provided for the Arteriotomy Closure Devices market.
• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Reasons to Buy

The model will enable you to:

• Understand the impact of COVID-19 on the Arteriotomy Closure Devices market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving the Arteriotomy Closure Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Arteriotomy Closure Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
• Track device sales in the global and country-specific Arteriotomy Closure Devices market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.